We are live on ! Find out more
BLFS icon

BioLife Solutions

160 hedge funds and large institutions have $509M invested in BioLife Solutions in 2022 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 73 increasing their positions, 40 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more repeat investments, than reductions

Existing positions increased: 73 | Existing positions reduced: 40

2.45% more ownership

Funds ownership: 84.44%86.89% (+2.5%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

4% less first-time investments, than exits

New positions opened: 24 | Existing positions closed: 25

2% less funds holding

Funds holding: 164160 (-4)

36% less capital invested

Capital invested by funds: $797M → $509M (-$288M)

99% less call options, than puts

Call options by funds: $6K | Put options by funds: $524K

Holders
160
Holders Change
-4
Holders Change %
-2.44%
% of All Funds
2.7%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
24
Increased
73
Reduced
40
Closed
25
Calls
$6K
Puts
$524K
Net Calls
-$518K
Net Calls Change
+$419K
Name Holding Trade Value Shares
Change
Change in
Stake
GA
26
Gagnon Advisors
New York
$4.21M +$1.45M +98,942 +48%
BCIM
27
British Columbia Investment Management
British Columbia, Canada
$4.04M
Thrivent Financial for Lutherans
28
Thrivent Financial for Lutherans
Minnesota
$3.86M +$983K +66,960 +32%
PC
29
Pier Capital
Connecticut
$3.81M +$857K +58,381 +27%
SIMG
30
Stephens Investment Management Group
Texas
$3.5M
Bank of America
31
Bank of America
North Carolina
$3.16M -$3.06M -208,655 -48%
Charles Schwab
32
Charles Schwab
California
$3.12M +$784K +53,425 +31%
Russell Investments Group
33
Russell Investments Group
United Kingdom
$3.07M -$3.4M -231,568 -51%
Victory Capital Management
34
Victory Capital Management
Texas
$2.93M -$450K -30,653 -13%
MIM
35
Meros Investment Management
Texas
$2.74M +$2.2M +150,134 +310%
Principal Financial Group
36
Principal Financial Group
Iowa
$2.67M -$132K -9,014 -4%
MAP
37
Moody Aldrich Partners
Massachusetts
$2.55M -$532K -36,222 -16%
Renaissance Technologies
38
Renaissance Technologies
New York
$2.48M +$2.22M +151,600 +549%
BFS
39
Bard Financial Services
Connecticut
$2.39M
SI
40
Stephens Inc
Arkansas
$1.96M +$1.58M +107,800 +318%
PFM
41
Premier Fund Managers
United Kingdom
$1.91M
UIC
42
Uniplan Investment Counsel
Wisconsin
$1.86M +$1.98M +134,936 New
Aberdeen Group
43
Aberdeen Group
United Kingdom
$1.73M -$142K -9,673 -7%
CIBC Private Wealth Group
44
CIBC Private Wealth Group
Georgia
$1.66M
N
45
Nuveen
North Carolina
$1.49M -$5.13M -349,458 -76%
AI
46
Acuitas Investments
Washington
$1.44M +$1.53M +104,002 New
AG
47
Algert Global
California
$1.4M +$1.48M +101,141 New
MPAM
48
Monarch Partners Asset Management
Massachusetts
$1.38M +$658K +44,825 +82%
HighTower Advisors
49
HighTower Advisors
Illinois
$1.29M +$1.18M +80,454 +604%
B
50
Barings
North Carolina
$1.26M

BLFS Hedge Fund Activity: Q2 2022 in Review

160 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q2 2022, worth a combined $509M — down 36% from $797M a quarter earlier.

Sellers outnumbered buyers: 25 funds closed out of BLFS and 24 opened new positions — a net loss of 1 holder — while 40 trimmed existing stakes and 73 added.

The largest buyer was BlackRock, adding an estimated $17.3M. The largest seller was Marshall Wace, exiting entirely with an estimated $20.1M sold.

  • 160 institutional investors held BioLife Solutions (BLFS) as of Q2 2022, down from 164 in Q1 2022.
  • Funds reported $509M of BioLife Solutions stock for Q2 2022, down 36% quarter-over-quarter.
  • 24 funds opened new BioLife Solutions positions in Q2 2022 and 25 closed out, a net change of -1 holder.
  • The largest BioLife Solutions buyer in Q2 2022 was BlackRock, an estimated $17.3M added.
  • The largest BioLife Solutions seller in Q2 2022 was Marshall Wace, an estimated $20.1M sold.

Based on aggregated 13F filings for Q2 2022.